Barclays PLC Dr Reddys Laboratories LTD Transaction History

Barclays PLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$51.15 - $57.45 $450,375 - $505,847	8,805 New	8,805 $456,000
Q4 2021 Feb 14, 2022	SELL	$59.5 - $67.25 $172,550 - $195,025	-2,900 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$60.19 - $75.29 $497,771 - $622,648	-8,270 Reduced 74.04%	2,900 $189,000
Q2 2021 Aug 13, 2021	BUY	$62.12 - $74.2 $499,569 - $596,716	8,042 Added 257.1%	11,170 $821,000
Q1 2021 May 13, 2021	BUY	$57.98 - $73.08 $100,189 - $126,282	1,728 Added 123.43%	3,128 $192,000
Q2 2020 Aug 12, 2020	BUY	$39.55 - $54.65 $55,369 - $76,510	1,400 New	1,400 $74,000
Q1 2020 May 13, 2020	SELL	$34.75 - $45.85 $79,751 - $105,225	-2,295 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$36.66 - $41.78 $1.13 Million - $1.29 Million	-30,889 Reduced 93.08%	2,295 $93,000
Q3 2019 Nov 14, 2019	BUY	$34.82 - $39.26 $450,570 - $508,024	12,940 Added 63.92%	33,184 $1.26 Million
Q2 2019 Aug 14, 2019	BUY	$36.05 - $42.76 $593,383 - $703,829	16,460 Added 434.99%	20,244 $758,000
Q1 2019 May 15, 2019	BUY	$35.77 - $40.57 $27,292 - $30,954	763 Added 25.26%	3,784 $153,000
Q4 2018 Feb 14, 2019	BUY	$31.89 - $38.44 $73,889 - $89,065	2,317 Added 329.12%	3,021 $114,000
Q3 2018 Nov 14, 2018	BUY	$29.25 - $36.73 $20,592 - $25,857	704 New	704 $24,000
Q1 2018 May 15, 2018	SELL	$31.93 - $39.54 $24,298 - $30,089	-761 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$34.15 - $37.62 $7,171 - $7,900	210 Added 38.11%	761 $29,000
Q3 2017 Nov 14, 2017	BUY	$30.11 - $37.72 $16,590 - $20,783	551	551 $20,000

256

37.9M

12.7K

6.1K

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.31B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.